World's Best Scientists 2026 revealed!
Judy C. Boughey

Judy C. Boughey

D-Index & Metrics

Medicine

D-Index
85
Citations
25178
World Ranking
14660
National Ranking
7417

Overview

Judy C. Boughey is affiliated with the Mayo Clinic in the United States and has contributed to research primarily in the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their published work spans numerous aspects of cancer research, oncology, surgery, pathology, and radiology with a particular focus on breast cancer.

The scientist's main research domains include:

  • Cancer Research
  • Oncology
  • Surgery
  • Pathology and Forensic Medicine
  • Radiology, Nuclear Medicine and Imaging

Boughey's work largely revolves around breast cancer, including studies on breast cancer treatment, breast lesions and carcinomas, breast implant and reconstruction, cancer genomics and diagnostics, cancer treatment and pharmacology, HER2/EGFR in cancer research, and advanced breast cancer therapies.

The most frequently published venues for their research include:

  • Annals of Surgical Oncology
  • Cancer Research
  • Journal of Clinical Oncology
  • Clinical Cancer Research
  • Breast Cancer Research and Treatment

Frequent collaborators in their research include:

  • Matthew P. Goetz
  • Tanya L. Hoskin
  • Laura J. Esserman
  • Christina Yau
  • Krishna R. Kalari

Notable recent publications by Judy C. Boughey feature contributions on the following:

  • "Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer" (2020, JAMA Oncology)
  • "Management of Hereditary Breast Cancer: American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Guideline" (2020, Journal of Clinical Oncology)
  • "Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II/III breast cancer: Results from the adaptively randomized I-SPY2 trial" (2021, Cancer Cell)
  • "Association of Event-Free and Distant Recurrence-Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer" (2020, JAMA Oncology)
  • "Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy in Patients With Node-Positive Breast Cancer: The ACOSOG Z1071 (Alliance) Clinical Trial" (2020, UNC Libraries)

Best Publications

  • Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy in Patients With Node-Positive Breast Cancer: The ACOSOG Z1071 (Alliance) Clinical Trial

    Judy C. Boughey;Vera J. Suman;Elizabeth A. Mittendorf;Gretchen M. Ahrendt

  • Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer: An Analysis of the Ongoing Phase 2 Adaptively Randomized I-SPY2 Trial

    Rita Nanda;Minetta C Liu;Christina Yau;Rebecca Shatsky

  • Adaptive Randomization of Veliparib–Carboplatin Treatment in Breast Cancer

    Hope S. Rugo;Olufunmilayo I. Olopade;Angela DeMichele;Christina Yau

  • Identification and Resection of Clipped Node Decreases the False-negative Rate of Sentinel Lymph Node Surgery in Patients Presenting With Node-positive Breast Cancer (T0-T4, N1-N2) Who Receive Neoadjuvant Chemotherapy: Results From ACOSOG Z1071 (Alliance).

    Judy C. Boughey;Karla V. Ballman;Huong T. Le-Petross;Linda M. McCall

  • Trends in Mastectomy Rates at the Mayo Clinic Rochester: Effect of Surgical Year and Preoperative Magnetic Resonance Imaging

    Rajini Katipamula;Amy C. Degnim;Tanya Hoskin;Judy C. Boughey

  • Adaptive Randomization of Neratinib in Early Breast Cancer

    John W Park;Minetta C Liu;Douglas Yee;Christina Yau

  • Tumor biology correlates with rates of breast-conserving surgery and pathologic complete response after neoadjuvant chemotherapy for breast cancer: findings from the ACOSOG Z1071 (Alliance) prospective multicenter clinical trial

    Judy C. Boughey;Linda M. McCall;Karla V. Ballman;Elizabeth A. Mittendorf

  • Consensus Guidelines on Genetic` Testing for Hereditary Breast Cancer from the American Society of Breast Surgeons

    Eric R. Manahan;Henry M. Kuerer;Molly Sebastian;Kevin S. Hughes

  • Standardization of pathologic evaluation and reporting of postneoadjuvant specimens in clinical trials of breast cancer : recommendations from an international working group

    Elena Provenzano;Veerle Bossuyt;Giuseppe Viale;David Cameron

  • Management of Hereditary Breast Cancer: American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Guideline.

    Nadine M. Tung;Judy C. Boughey;Lori J. Pierce;Mark E. Robson

  • Pembrolizumab plus standard neoadjuvant therapy for high-risk breast cancer (BC): Results from I-SPY 2.

    Rita Nanda;Minetta C. Liu;Christina Yau;Smita Asare

  • Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration

    V. Bossuyt;E. Provenzano;W. F. Symmans;J. C. Boughey

  • Current status of radioactive seed for localization of non palpable breast lesions.

    James W. Jakub;Richard J. Gray;Amy C. Degnim;Judy C. Boughey

  • Fluorouracil, epirubicin, and cyclophosphamide (FEC-75) followed by paclitaxel plus trastuzumab versus paclitaxel plus trastuzumab followed by FEC-75 plus trastuzumab as neoadjuvant treatment for patients with HER2-positive breast cancer (Z1041): a randomised, controlled, phase 3 trial.

    Aman U Buzdar;Vera J Suman;Funda Meric-Bernstam;A Marilyn Leitch

  • Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II/III breast cancer: Results from the adaptively randomized I-SPY2 trial

    Lajos Pusztai;Christina Yau;Denise M. Wolf;Hyo S. Han

  • Axillary Ultrasound After Neoadjuvant Chemotherapy and Its Impact on Sentinel Lymph Node Surgery: Results From the American College of Surgeons Oncology Group Z1071 Trial (Alliance)

    Judy C. Boughey;Karla V. Ballman;Kelly K. Hunt;Linda M. McCall

  • The Clinical Significance of Breast-only and Node-only Pathologic Complete Response (pCR) After Neoadjuvant Chemotherapy (NACT): A Review of 20,000 Breast Cancer Patients in the National Cancer Data Base (NCDB)

    Oluwadamilola M. Fayanju;Oluwadamilola M. Fayanju;Yi Ren;Samantha M. Thomas;Rachel A. Greenup;Rachel A. Greenup

  • Contralateral Prophylactic Mastectomy is Associated with a Survival Advantage in High-Risk Women with a Personal History of Breast Cancer

    Judy C. Boughey;Tanya L. Hoskin;Amy C. Degnim;Thomas A. Sellers

  • Novel Methylated Biomarkers and a Robust Assay to Detect Circulating Tumor DNA in Metastatic Breast Cancer

    Mary Jo Fackler;Zoila Lopez Bujanda;Christopher Umbricht;Wei Wen Teo

  • DNA methyltransferase expression in triple-negative breast cancer predicts sensitivity to decitabine

    Jia Yu;Bo Qin;Ann M. Moyer;Somaira Nowsheen

Frequent Co-Authors

Matthew P. Goetz
Matthew P. Goetz Mayo Clinic
Liewei Wang
Liewei Wang Mayo Clinic
Kelly K. Hunt
Kelly K. Hunt The University of Texas MD Anderson Cancer Center
Laura J. Esserman
Laura J. Esserman University of California, San Francisco
Vera J. Suman
Vera J. Suman Mayo Clinic
Christina Yau
Christina Yau University of California, San Francisco
James N. Ingle
James N. Ingle Mayo Clinic
Kathy S. Albain
Kathy S. Albain Loyola University Chicago
Donald A. Berry
Donald A. Berry The University of Texas MD Anderson Cancer Center
Claudine Isaacs
Claudine Isaacs Georgetown University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering Medicine in the USA, there are several online degrees and alternative career routes to explore. These accredited programs often offer flexibility—making them ideal for working professionals and those looking to advance or pivot in healthcare.

For nurses aiming to reach the highest level of clinical practice, easiest online dnp programs can be a practical choice, providing advanced education through accessible online platforms. Alternatively, if you prefer a quicker entry into nursing, fast track lpn programs can help you move into the workforce efficiently.

Those interested in mental health roles may consider accelerated msn psychiatric np programs, designed to fast-track your specialization as a psychiatric nurse practitioner. For students looking beyond clinical roles, a healthcare administration degree online offers a foundation in leadership and management within the healthcare sector.

Whether your interests lie in advanced practice, administration, or entering the field quickly, these online pathways provide flexible, affordable, and accelerated options for building a career in healthcare.

Best Scientists Citing Judy C. Boughey

Trending Scientists